Prof. Lu Renquan

Professor Lu Renquan is the Director of the Department of Laboratory Medicine at the Pudong Campus of Fudan University Shanghai Cancer Center. He serves as Professor, Doctoral Supervisor, and Postdoctoral Cooperative Supervisor. Honored as a Pujiang Talent and Shanghai Discipline Academic Leader, Prof. Lu is a distinguished expert in laboratory medicine, tumor immunology, tumor markers, and translational diagnostics.

Prof. Lu currently chairs the Tumor Marker Committee of the Shanghai Anti-Cancer Association and the Tumor Immunology Committee of the Chinese Association of Integrative Medicine, and serves as Chairman-elect of the Laboratory Medicine Committee of the Shanghai Association of Integrative Medicine. He is also Vice Chair of the Laboratory Medicine Branch of the Shanghai Medical Association and Vice Chair of the Tumor Testing and Companion Diagnostics Committee of the China Anti-Cancer Association, with concurrent roles as national society council member and review expert of the National Natural Science Foundation of China.

As Chief Scientist of a National Key Research and Development Program and Principal Investigator of five NSFC-funded projects, Prof. Lu leads research spanning cancer biomarkers, tumor immunology, and precision companion diagnostics. In recent years, he has published over 60 research articles as the corresponding author in highly influential journals such as Nature Communications, Cell Discovery, Journal of Immunotherapy for Cancer, Journal of hematology and oncology, Cell Death and Diseases and Oncogene; he also applied for 4 national invention patents and successfully converted 2 of them. His contributions have earned multiple national and municipal honors, including the Second Prize of the China Anti-Cancer Association Science and Technology Award (2019), the First Prize of the Shanghai Anti-Cancer Science and Technology Award (2018, 2020, 2025), the Gold Award of the Shanghai Outstanding Invention Award (2021), and the Shanghai Medical Innovation Award (2023).